W celu świadczenia usług na najwyższym poziomie stosujemy pliki cookies. Korzystanie z naszej witryny oznacza, że będą one zamieszczane w Państwa urządzeniu. W każdym momencie można dokonać zmiany ustawień Państwa przeglądarki. Zobacz politykę Cookies

X

Recommendation of the President

29 August, 2022

Recommendation of the President – on qualifying selected diagnostic, ultrasound, invasive, electrophysiological, and functional examinations as well as specialist advice and consultations for the list of guaranteed health care services in the scope of primary health care

29 August, 2022

Recommendation of the President – Milupa Basic-P

18 August, 2022

Recommendation of the President – Rezurock (belumosudil)

28 July, 2022

Recommendation of the President – Opdivo (nivolumab) in combination with Yervoy (ipilimumab)

13 July, 2022

Announcement of the President – recommendation on the change of the method or level of healthcare service financing

05 July, 2022

Recommendation of the President – Treatment of advanced colorectal cancer (ICD-10: C18–C20)

Home page

News Publications Publikacje BIP

#webinar agenda Aktualności azathioprinum Bimzelx Collegium AOTMiT colorectal cancer communication Communication from the Transparency Council Communication on the Tariff Council Cost Accounting Standard Council for Tariffs Affairs covering neonatal care cyclophosphamidum Data acquisition dental treatment services diseases of the organ of vision drug programme Empliciti entecavirum etanercept Fycompa gastroscopy glaucoma health policy program health policy programme health policy programme on breast cancer health policy programme on infertility treatment Health Policy Programmes Impavido in vitro Inovelon Jardiance Meeting of the Transparency Council methotrexatum Milupa Basic-P minimum wage increases mycophenolate mofetil new new tariffs news Notice Notice of the President Ontozry Onureg Opdivo Opdivo (nivolumab)opinion Opinion of the President Opinion of the Transparency Council Ospolot Ozurdex perinatal care Ponvory Position of the Transparency Council Press conference Recommendation Recommendation of the President Renastep report Rezurock sirolimus Suliqua Tariff Council Tariffs Council tenofovirum disoproxilum the drug programme B.44 the drug programme B.82 The Meeting of the Tariffs Council trainings Transparency Council Tremfya update Vivitrol Yervoy